Current Issue - March 2019, Volume 13, Issue No. 1

1. Stockwell RA. Chondrocytes. J Clin Pathol Suppl (R Coll Pathol). 1978; 12: 7-13.
2. Archer CW, Morrison H, Pitsillides AA. Cellular aspects of the development of diarthrodial joints and articular cartilage. J Anat. 1994; 184 (Pt 3): 447-56.
3. Jafaradeh SR, Felson DT. Updated estimates suggest a much higher prevalence of arthritis in United States adults than previous ones. Arthritis Rheumatol. 2018;70(2): 185-92.
4. Nelson L, Fairclough J, Archer CW. Use of stem cells in the biological repair of articular cartilage. Expert Opin Biol Ther. 2010; 10(1): 43-55.
5. Schiphof D, van den Driest JJ, Runhaar J. Osteoarthritis year in review 2017: rehabilitation and outcomes. Osteoarthritis Cartilage. 2018; 26(3): 326-40.
6. Williams R, Khan IM, Richardson K, Nelson L, McCarthy HE, Analbelsi T, et al. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. Plos One. 2010; 5(10): 14.
7. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 2004; 50(5): 1522-32.
8. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res. 2004(427 Suppl): S27-S36.
9. Maroudas A, Schneiderman R, Popper O. The role of water, proteoglycan, and collagen in solute transport in cartilage. In: Kuettner K (editors). Articular Cartilage and Osteoarthritis. Raven Press: New York; 1992: 355-71.
10. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage. associations with degenerative changes. Arthritis Rheum. 2001; 44(3): 585-94.
11. Bank RA, Bayliss MT, Lafeber F, Maroudas A, Tekoppele JM. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage - the age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem J. 1998; 330(Pt 1): 345-51.
12. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9(8): 581-93.
13. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011; 68(16): 2667-88.
14. Welton JL, Brennan P, Gurney M, Webber JP, Spary LK, Carton DG, et al. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. J Extracell Vesicles. 2016; 5(1): 31209.
15. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014; 30: 255-89.
16. Yanez-Mo M, Siljander PRM, Andreu Z, Zavec AB, Borras FE, Buzas El, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015; 4(1): 27066.
17. Ridger VC, Boulanger CM, Angelillo-Scherrer A, Badimon L, Blanc-Brude O, Bochaton-Piallat ML, et al. Microvesicles in vascular homeostasis and diseases Position paper of the European society of cardiology (ESC) working group on atherosclerosis and vascular biology. Thromb Haemost. 2017; 117(7): 1296-316.
18. Salomon C, Kobayashi M, Ashman K, Sobrevia L, Mitchell MD, Rice GE. Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes. Plos One. 2013; 8(11): e79636.
19. Isola AL, Chen S. Extracellular vesicles: important players in immune homeostasis. Ann Transl Med. 2017; 5(Suppl 1): S16.
20. Antony B, Venn A, Cicutinni F, March L, Blizzard L, Dwyer T, et al. Association of physical activity and physical performance with tibial cartilage volume and bone area in young adults. Arthritis Res Ther. 2015; 17: 298.
21. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010; 70(23): 9621-30.
22. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005; 45(10): 1622-30.
23. Buzas EI, Gyorgy B, Nagy G, Falus A, Gay S. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol. 2014; 10(6): 356-64.
24. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn F, Kraan MC, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 2002; 46(11): 2857-66.
25. Domenis R, Zanutel R, Caponnetto F, Toffoletto B, Cifu A, Pistis C, et al. Characterization of the proinflammatory profile of synovial fluid-derived exosomes of patients with osteoarthritis. Mediators of Inflamm. 2017: 11.
26. Withrow J, Murphy C, Liu YT, Hunter M, Fulzele S, Hamrick MW. Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2016; 18: 286.
27. Martel-Pelletier J, Tat SK, Pelletier JP. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review. Osteoarthritis Cartilage. 2010; 18 Suppl 1: S7-11.
28. Bonnet CS, Williams AS, Gilbert SJ, Harvey AK, Evans BA, Mason DJ. AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis. Ann Rheum Dis. 2015; 74(1): 242-51.
29. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002; 39(1-2): 237-46.
30. Kato T, Miyaki S, Ishitobi H, Nakamura Y, Nakasa T, Lotz MK, et al. Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res Ther. 2014; 16(4): R163.
31. Yang Q, Peng J, Lu SB, Guo QY, Zhao B, Zhang L, et al. Evaluation of an extracellular matrix-derived acellular biphasic scaffold/cell construct in the repair of a large articular high-load-bearing osteochondral defect in a canine model. Chin Med J (Engl). 2011; 124(23): 3930-8.
32. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007; 211(1): 27-35.
33. Vinatier C, Guicheux J. Cartilage tissue engineering: From biomaterials and stem cells to osteoarthritis treatments. Ann Phys Rehabil Med. 2016; 59(3): 139-44.
34. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJR, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci. 2004; 117(6): 889-97.
35. Khan IM, Bishop JC, Gilbert S, Archer CW. Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. Osteoarthritis Cartilage. 2009; 17(4): 518-28.
36. Fellows CR, Williams R, Davies IR, Gohil K, Baird DM, Fairclough J, et al. Characterisation of a divergent progenitor cell sub-populations in human osteoarthritic cartilage: the role of telomere erosion and replicative senescence. Sci Rep. 2017; 7: 41421.
37. Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noel D. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep. 2017; 7(1): 12.
38. Zhang S, Chu WC, Lai RC, Lim SK, Hui JHP, Toh WS. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage. 2016; 24(12): 2135-40.
39. Zhang SP, Chuah SJ, Lai RC, Hui JHP, Lim SK, Toh WS. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018; 156: 16-27.
40. Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017; 7(1): 180-95.
41. Yang T, Gu HH, Chen XF, Fu SZ, Wang C, Xu HF, et al. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo. J Surg Res. 2014; 192(2): 317-25.
42. Xin LZ, Govindasamy V, Musa S, Abu Kasim NH. Dental stem cells as an alternative source for cardiac regeneration. Med Hypotheses. 2013; 81(4): 704-6.
43. Andersen HH, Duroux M, Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis. 2014; 71: 159-68.
44. Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum. 2009; 60(4): 1035-41.
45. Li X, Gibson G, Kim JS, Kroin J, Xu S, van Wijnen AJ, et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene. 2011; 480(1-2): 34-41.
46. Hong E, Reddi AH. MicroRNAs in chondrogenesis, articular cartilage, and osteoarthritis: implications for tissue engineering. Tissue Eng Part B Rev. 2012; 18(6): 445-53.
47. Miyaki S, Nakasa T, Otsuki S, Grogan SP, Higashiyama R, Inoue A, et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009; 60(9): 2723-30.
48. Karlsen TA, de Souza GA, Odegaard B, Engebretsen L, Brinchmann JE. microRNA-140 Inhibits Inflammation and stimulates chondrogenesis in a model of interleukin 1β-induced osteoarthritis. Mol Ther Nucleic Acids. 2016; 5(10): e373.
49. Kolhe R, Hunter M, Liu SY, Jadeja RN, Pundkar C, Mondal AK, et al. Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci Rep. 2017; 7: 2029.
50. Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017; 35(4): 851-8.
51. Cui GH, Wang YY, Li CJ, Shi CH, Wang WS. Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis. Exp Ther Med. 2016; 12(5): 3390-400.

Abstract   |   Reference